Join to View Full Profile
2255 Kenny RdColumbus, OH 43221
Dr. Hasanov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2017 - 2019
UMass Chan - BaystateInternship, Surgery, 2016 - 2017
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2012 - 2016
Texas A&M; Health Science Center College of MedicinePost-Doctoral Fellowship, 2012 - 2016
Hacettepe University FOMClass of 2012
Certifications & Licensure
TX State Medical License 2017 - Present
OH State Medical License 2023 - 2027
MA State Medical License 2016 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- STARLITE 1: Phase 1b/2 Study of CombinedLu-Girentuximab plus Cabozantinib and Nivolumab in Treatment-naïve Patients with Advanced Clear-cell Renal Cell Carcinoma.Elshad Hasanov, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks
European Urology Focus. 2025-04-26 - Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma.Vinita Akula, Lily Chen, Yusuf Acikgoz, Katherine Klein, Betul Gok Yavuz
NPJ Precision Oncology. 2025-03-06 - Efficacy and safety of nivolumab plus ipilimumab in patients with metastatic variant histology (non-clear cell) renal cell carcinoma.Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, Kiran L Malikayil, Devaki Shilpa Surasi
Journal for Immunotherapy of Cancer. 2025-02-12
Press Mentions
AACR: Single-Cell Study Uncovers Distinct Immunosuppressive Tumor Microenvironment in Brain Metastases from Kidney CancerApril 18th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
